Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva
Year: 2007
Type: article
Study design: Case Report
Source: Gynecologic Oncology
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Topic: Genital Health and Disease
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2059958002
